Drugs / DSXS topical
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02933866 | Mar → Nov 2016 | psoriasis | Sun Pharmaceutical Industries, Inc. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DSXS topical | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02933866 ↗ |
| Route | Topical | “topical treatment” NCT02933866 ↗ |